Related Experiment Video
Updated: Jul 2, 2025

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
Published on: June 2, 2021
Transcriptome-wide association studies associated with Crohn's disease: challenges and perspectives
1Laboratory of Medicine, Baoshan Branch, Ren Ji Hospital, School of Medicine, Nephrology department, Shanghai Jiao Tong University, 1058 Huanzhen Northroad, Shanghai, 200444, China.
Transcriptome-wide association studies (TWAS) identify genes linked to Crohn's disease (CD) pathogenesis. This review highlights ileal lipid metabolism and colonic extracellular vesicles as potential factors in CD development.
Area of Science:
- Genetics
- Gastroenterology
- Computational Biology
Background:
- Crohn's disease (CD) is a chronic, progressive inflammatory condition affecting the gastrointestinal tract and other organs.
- Genome-wide association studies (GWAS) have identified numerous genetic loci associated with CD risk.
- Transcriptome-wide association studies (TWAS) integrate gene expression data with genetic association data to identify specific genes contributing to disease susceptibility.
Purpose of the Study:
- To review and summarize seven reported TWAS of Crohn's disease.
- To discuss the methodologies and key steps in TWAS that influence the prioritization of susceptibility genes.
- To explore tissue-specific susceptibility genes and their potential pathological mechanisms in CD.
Main Methods:
- Systematic review of published TWAS studies on Crohn's disease.
- Analysis of study designs, methodologies, and gene prioritization strategies used in TWAS.
- Gene Ontology (GO) pathway enrichment analysis for identified susceptibility genes.
Main Results:
- Identified potential roles for ileal lipid metabolism and colonic extracellular vesicles in CD pathogenesis.
- Highlighted significant variability and low reproducibility in current TWAS findings for CD.
- Summarized key methods influencing susceptibility gene identification and prioritization.
Conclusions:
- TWAS is a valuable approach for identifying CD susceptibility genes, but methodological inconsistencies limit reproducibility.
- Ileal lipid metabolism and colonic extracellular vesicles represent promising avenues for further research into CD pathology.
- Future TWAS efforts should focus on large-scale, unified cohorts and standardized analysis pipelines for improved reliability.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

